Yan-Ying Qian Zhi-Juan Dai Lu-Ya Ruan You-Jin Pan Jian Jin Meng-Te Shi Yao-Xin Zhu Chao-Ming Wu
10.2147/DDDT.S192632
Drug Des Devel Ther
2019 Apr 10;13:1127-1133.
adefovir dipivoxil chronic hepatitis b virus hypophosphatemia osteomalacia
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/31118563/
Adenine / analogs & derivatives Hepatitis B, Chronic / complications Hypophosphatemia / chemically induced Kidney Diseases / chemically induced Kidney Diseases / prevention & control Organophosphonates / administration & dosage Organophosphonates / adverse effects Osteomalacia / chemically induced
Adenine / analogs & derivatives Hepatitis B, Chronic / complications Hypophosphatemia / chemically induced Kidney Diseases / chemically induced Kidney Diseases / prevention & control Organophosphonates / administration & dosage Organophosphonates / adverse effects Osteomalacia / chemically induced Case Reports Adenine / administration & dosage Adenine / adverse effects Adenine / therapeutic use Aged Dose-Response Relationship, Drug Fanconi Syndrome / chemically induced Fanconi Syndrome / complications Female Hepatitis B, Chronic / drug therapy Humans Hypophosphatemia / complications Kidney Diseases / complications Male Middle Aged Organophosphonates / therapeutic use Osteomalacia / complications Organophosphonates Adenine adefovir dipivoxil
PMC6498959
31118563
Low-dose adefovir dipivoxil-induced hypophosphatemia osteomalacia in five chronic hepatitis B virus-infected patients. Is low-dose adefovir dipivoxil-induced nephrotoxicity completely reversible?
2019